Introduction: Redefining the Patient Role in Global Health

For decades, the global medical community viewed patients primarily as subjects of study rather than active partners in the research process. However, a significant shift is occurring as healthcare systems move toward more collaborative models. Patient and Public Involvement, commonly known as PPI, represents a movement where research is carried out "with" or "by" members of the public rather than "to" or "for" them. While high-income countries have successfully integrated these practices, PPI in LMIC research remains significantly underdeveloped. Low- and middle-income countries (LMICs), including India, face unique structural and cultural challenges that often limit patient engagement to simple recruitment or data collection. To address this, recent evidence highlights the urgent need for structured programs that move beyond tokenism and embrace genuine partnership.

Developing structured involvement is not merely an ethical preference; it is a clinical necessity. When patients contribute to study design, they ensure that the research questions remain relevant to real-world needs. Furthermore, involvement helps researchers navigate cultural sensitivities that might otherwise hinder data collection or treatment adherence. Consequently, establishing a formal framework for involvement in LMICs is essential for strengthening the equity and accountability of global health research. This transformation requires moving away from informal community engagement toward a coordinated, infrastructure-heavy approach that empowers the patient voice across the entire research lifecycle.

The Evidence Gap: Why Structured PPI is Lacking

A recent scoping review of health research between 2013 and 2025 reveals a startling disparity in how involvement is documented globally. Despite thousands of studies conducted in LMICs, only a handful describe a structured approach to patient involvement. Most initiatives currently labeled as engagement are actually limited to community outreach or consultation. These activities, while valuable, do not constitute a structured PPI program because they often lack formalized training, institutional support, or longitudinal assessment. In the Indian context, the primary focus has historically remained on ethical compliance and informed consent. While these are critical, they do not provide patients with the agency to influence the research agenda or the methodology of a clinical trial.

Several factors contribute to this persistent evidence gap. For instance, many researchers in LMICs operate within hierarchical academic cultures where the expertise of a layperson is rarely equated with clinical knowledge. Moreover, many institutions lack the dedicated funding required to compensate patient contributors for their time and expertise. This lack of reimbursement creates a significant barrier, particularly for marginalized populations who cannot afford to participate in unpaid advisory roles. Additionally, the digital divide and literacy barriers often exclude the very populations who would benefit most from inclusive research practices. Addressing these gaps requires a move toward a more systematic and well-documented approach to involvement.

Overcoming Cultural Barriers and Hierarchical Structures

Implementing PPI in LMIC research requires a deep understanding of local social dynamics. In many Asian and African healthcare settings, the doctor-patient relationship is traditionally paternalistic. Patients may feel hesitant to criticize a research protocol or suggest changes to a study design out of respect for the investigator’s authority. This power imbalance often leads to a "tick-box" exercise where patients are consulted but their feedback is never truly integrated into the final protocol. To break these patterns, researchers must intentionally create safe spaces where patient advisors feel empowered to share their lived experiences without fear of repercussion or dismissal.

Language also plays a pivotal role in the success of involvement programs. Much of the global guidance on PPI is written in English and uses technical jargon that may not translate well into local dialects or cultural contexts. Therefore, cultural adaptation is essential. This involves more than just translating documents; it requires adapting the very concepts of involvement to fit local social structures. Specifically, involving community leaders or patient advocacy groups can help bridge the gap between scientific teams and the public. By prioritizing culturally grounded development, researchers can ensure that involvement is meaningful rather than merely performative. This approach fosters trust, which is the cornerstone of any successful long-term research partnership.

The LMIC PPI Programme Development Framework

To provide a roadmap for future practice, educators and researchers have proposed a new LMIC-specific framework. This framework consists of five essential pillars designed to provide the infrastructure necessary for sustained involvement. The first pillar is foundational training. Both researchers and patient contributors require tailored education to understand their roles and responsibilities within a partnership. Researchers must learn how to facilitate inclusive discussions, while patients need to understand the basic mechanics of the research process. Secondly, the framework emphasizes the need for dedicated program infrastructure. This includes hiring PPI coordinators who serve as intermediaries between the public and the scientific team, ensuring that communication remains clear and consistent.

The third pillar is culturally grounded development, which ensures that involvement practices respect local norms and values. Fourthly, the framework advocates for involvement across the entire research cycle, from the initial prioritization of research topics to the dissemination of results. Finally, the framework includes a robust monitoring and evaluation component. Without measuring the impact of involvement, it is impossible to refine practices or demonstrate the value of PPI to funding bodies. By adopting this five-pillar approach, Indian research institutions can move toward a more equitable model that treats patients as co-creators of knowledge. This systematic method provides the stability needed to maintain involvement beyond the lifecycle of a single study.

Strategic Benefits for Clinical Research in India

Integrating structured PPI offers numerous strategic advantages for the Indian clinical research landscape. One of the most immediate benefits is improved participant recruitment and retention. When patients help design recruitment materials, the language used is often more accessible and persuasive, leading to higher enrollment rates. Furthermore, patient involvement helps identify potential logistical barriers, such as transport costs or inconvenient clinic hours, that might otherwise lead to high dropout rates. By addressing these practical concerns early in the design phase, researchers can significantly improve the efficiency and cost-effectiveness of their trials. Consequently, the data generated is often of higher quality and more reflective of the diverse Indian population.

In addition to operational benefits, PPI enhances the ethical integrity of research. While Institutional Ethics Committees (IECs) provide a necessary regulatory check, they cannot replace the perspective of someone living with a specific health condition. Patient advisors can highlight potential risks or burdens that a clinician might overlook. This proactive approach to ethics aligns with the evolving regulatory environment in India, where the CDSCO and ICMR are increasingly emphasizing patient-centricity. Ultimately, moving toward a structured PPI model will elevate the status of Indian health research on the global stage, making it more competitive for international grants and collaborations. Strengthening these partnerships is a vital step toward achieving health justice and equity.

The Role of Institutions and Future Policy

For PPI in LMIC research to become the standard, institutional support is non-negotiable. Individual researchers cannot be expected to manage complex involvement programs without the backing of their universities or hospitals. This support must include the creation of standardized reimbursement policies for patient contributors, ensuring that participation is not a financial burden. Furthermore, research funding agencies must begin to mandate PPI as a requirement for grant applications, similar to the models used in high-income countries. This policy shift would provide the necessary incentive for institutions to invest in the training and coordination staff required to run effective programs.

Looking ahead, the integration of digital health technologies offers new opportunities for involvement, provided that the digital divide is managed carefully. Mobile apps and social media platforms can be used to facilitate ongoing dialogue between researchers and the public, even in remote areas. However, these tools must be used as a supplement to, rather than a replacement for, face-to-face engagement. As India continues to reform its clinical trial rules, the inclusion of structured involvement frameworks will be a key indicator of progress. By fostering a culture of partnership, the Indian medical community can ensure that its research is not only scientifically rigorous but also socially relevant and ethically sound.

Frequently Asked Questions

What is the main difference between community engagement and patient involvement?

Community engagement is often a broad, one-way process focused on sharing information or obtaining consent from a group. In contrast, Patient and Public Involvement (PPI) is a structured, two-way partnership where patients actively shape the research process itself. While engagement might involve a town hall meeting to explain a study, involvement means having a patient representative sit on the steering committee to help decide which outcomes the study should measure.

How does structured PPI impact the ethics of a clinical trial?

Structured PPI significantly strengthens research ethics by ensuring that the trial design respects the dignity and practical needs of participants. Patient advisors can identify hidden burdens, such as overly long questionnaires or invasive procedures that may not be strictly necessary. By addressing these issues before the trial begins, researchers minimize potential harm and ensure that the study is conducted in a way that is truly beneficial to the patient community.

Are there specific funding mechanisms for PPI in Indian research?

Currently, dedicated funding for PPI in India is limited but growing. Researchers should proactively include PPI costs, such as coordinator salaries and patient honoraria, in their primary grant budgets. Some international funders, such as the Wellcome Trust and NIHR, specifically look for PPI components in LMIC research applications. Additionally, some Indian institutions are beginning to set aside internal funds to support patient advisory groups as part of their commitment to social responsibility and research excellence.

Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or as a substitute for the professional judgment of a healthcare provider. Researchers should always comply with the latest ethical and regulatory requirements of the ICMR and CDSCO. Refer to the latest local and national guidelines for clinical practice.

References

Salim H et al. Structured patient and public involvement programme development in low- and middle-income country health research: a scoping review of evidence gaps and a framework for future practice. Res Involv Engagem. 2026 Jun 26. doi: undefined. PMID: 42363295.

Indian Council of Medical Research. Ethical Guidance for Non-Regulatory Clinical Trials. 2024.

Kapoor S, Gupta P. Ethics in clinical practice: A call for establishing clinical ethics committees in India. Natl Med J India. 2026;39:194-5. DOI: 10.25259/NMJI_1512_2024.